News

Biocon gets EU approval for diabetes drug, Liraglutide

The approval is for the generic versions of Victoza® and Saxenda®

Read More

Dec 27, 2024

By : Team ABLE

Biocon Biologics Earns Recognition for Intellectual Property Excellence

Asia IP Elite for 2024 is the world’s leading Intellectual Property (IP) publication.

Read More

Dec 27, 2024

By : Team ABLE

Biocon Celebrates 46th Founder Day with a Focus on Innovation and Social Impact

Reflecting on its 46-year journey, Biocon celebrates its evolution into a diversified biopharmaceutical enterprise dedicated to addressing global health disparities through affordable innovation. Biocon remains steadfast in its mission to create exponential and enduring value for stakeholders while improving the lives of millions of patients worldwide.

Read More

Dec 27, 2024

By : Team ABLE

Dr Cyrus Poonawalla Honored for Lifetime Achievement; Serum Institute Expands Global Vaccine Access

These partnerships underscore SII’s ongoing mission to provide high-quality, affordable vaccines worldwide and address pressing public health needs through collaboration and innovation.

Read More

Dec 26, 2024

By : Team ABLE

Superconvergence Event at Science Gallery Bengaluru

Superconvergence, an event celebrating the fusion of Biotechnology, AI, and Bioengineering, was held at Science Gallery Bengaluru

Read More

Dec 26, 2024

By : Team ABLE

 

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Indian Startup Delegations to the USA & UK

Applications Open

Focus Areas

Highlights